MX365914B - Forma de dosificación de topiramato dispersable rápidamente. - Google Patents
Forma de dosificación de topiramato dispersable rápidamente.Info
- Publication number
- MX365914B MX365914B MX2015012135A MX2015012135A MX365914B MX 365914 B MX365914 B MX 365914B MX 2015012135 A MX2015012135 A MX 2015012135A MX 2015012135 A MX2015012135 A MX 2015012135A MX 365914 B MX365914 B MX 365914B
- Authority
- MX
- Mexico
- Prior art keywords
- topiramate
- dosage form
- rapidly dispersible
- dispersible dosage
- taste
- Prior art date
Links
- KJADKKWYZYXHBB-XBWDGYHZSA-N Topiramic acid Chemical compound C1O[C@@]2(COS(N)(=O)=O)OC(C)(C)O[C@H]2[C@@H]2OC(C)(C)O[C@@H]21 KJADKKWYZYXHBB-XBWDGYHZSA-N 0.000 title abstract 5
- 229960004394 topiramate Drugs 0.000 title abstract 5
- 239000002552 dosage form Substances 0.000 title abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 239000002245 particle Substances 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 239000006185 dispersion Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 210000003296 saliva Anatomy 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/06—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of pills, lozenges or dragees
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Physiology (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361791592P | 2013-03-15 | 2013-03-15 | |
| PCT/US2014/029168 WO2014144661A1 (en) | 2013-03-15 | 2014-03-14 | Rapidly dispersible dosage form of topiramate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2015012135A MX2015012135A (es) | 2015-11-25 |
| MX365914B true MX365914B (es) | 2019-06-20 |
Family
ID=51537752
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015012135A MX365914B (es) | 2013-03-15 | 2014-03-14 | Forma de dosificación de topiramato dispersable rápidamente. |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US9492380B2 (OSRAM) |
| EP (1) | EP2968181B1 (OSRAM) |
| JP (1) | JP6466399B2 (OSRAM) |
| CN (1) | CN105050588B (OSRAM) |
| AU (2) | AU2014228861B2 (OSRAM) |
| CA (1) | CA2906172C (OSRAM) |
| ES (1) | ES2761407T3 (OSRAM) |
| HK (1) | HK1213473A1 (OSRAM) |
| MX (1) | MX365914B (OSRAM) |
| WO (1) | WO2014144661A1 (OSRAM) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0815387B8 (pt) * | 2007-08-13 | 2021-05-25 | Abuse Deterrent Pharmaceutical Llc | composição farmacêutica, método para fazer uma composição farmacêutica e uso da composição farmacêutica |
| CN109908355B (zh) | 2013-03-15 | 2022-11-15 | 阿普雷奇亚制药有限责任公司 | 包含左乙拉西坦的快速分散剂型 |
| US9339489B2 (en) | 2013-03-15 | 2016-05-17 | Aprecia Pharmaceuticals Company | Rapid disperse dosage form containing levetiracetam |
| CN104586871B (zh) * | 2014-12-27 | 2018-01-16 | 北京罗诺强施医药技术研发中心有限公司 | 包含托吡酯的药物组合物 |
| US20160243036A1 (en) * | 2015-02-25 | 2016-08-25 | Intelgenx Corp. | Film dosage forms containing amorphous active agents |
| AU2016272089B2 (en) | 2015-06-03 | 2021-02-18 | Triastek, Inc. | Dosage forms and use thereof |
| WO2017175792A1 (ja) * | 2016-04-06 | 2017-10-12 | アステラス製薬株式会社 | 速溶出性三次元造形物、速溶出性三次元造形物用フィラメント及び速溶出性三次元造形物用材料 |
| RU2722385C1 (ru) | 2016-09-02 | 2020-05-29 | Ново Футура ИВС | Одноразовый гриль и способ изготовления одноразового гриля |
| JP7191385B2 (ja) | 2017-01-26 | 2022-12-19 | トリアステック インコーポレイテッド | 特定の胃腸部位での制御放出の剤形 |
| CN107252418B (zh) * | 2017-05-17 | 2020-06-23 | 西安棣加生物科技有限公司 | 一种3d打印技术制备治疗低钾血症的口腔速崩片的方法 |
| CN107213126B (zh) * | 2017-05-17 | 2020-06-23 | 西安棣加生物科技有限公司 | 一种3d打印技术制备治疗高磷血症的口腔速崩片的方法 |
| US10703549B2 (en) * | 2017-06-30 | 2020-07-07 | The Procter And Gamble Company | Water soluble containers and methods of making them |
| WO2019086408A1 (en) * | 2017-11-02 | 2019-05-09 | Zambon S.P.A. | Pharmaceutical compositions comprising safinamide |
| EP3733166A4 (en) * | 2017-12-26 | 2021-11-17 | Towa Pharmaceutical Co., Ltd. | ORAL DISINTEGRATION CYCLIC TABLET |
| CN111698983B (zh) | 2018-01-09 | 2022-10-18 | 南京三迭纪医药科技有限公司 | 一种包含固定剂量adhd非兴奋剂和adhd兴奋剂的复方口服药物剂型 |
| WO2019199505A1 (en) * | 2018-04-10 | 2019-10-17 | Panacea Biomatx, Inc. | Method and system for making personalized nutritional and pharmaceutical formulations using additive manufacturing |
| AU2019337800A1 (en) * | 2018-09-14 | 2021-05-13 | Merck Patent Gmbh | Process for the preparation of a coated solid pharmaceutical dosage form |
| JP7614103B2 (ja) * | 2018-10-15 | 2025-01-15 | アプレシア・ファーマスーティカルズ・エルエルシー | 包装内に剤形を形成する方法およびシステム |
| EP3883546A1 (en) * | 2018-11-21 | 2021-09-29 | Rosemont Pharmaceuticals Ltd | Oral topiramate suspension formulations with extended shelf stability and enhanced bioavailability |
| CA3129404A1 (en) | 2019-02-22 | 2020-08-27 | Catalent U.K. Swindon Zydis Limited | Preserving functionally-coated api particles produced by solventless mixing processes in aqueous suspension |
| MX2021009679A (es) | 2019-02-22 | 2021-09-10 | Catalent Uk Swindon Zydis Ltd | Minimizacion de aglomeracion, aireacion y conservacion del revestimiento de composiciones farmaceuticas que comprenden ibuprofeno. |
| MX2021009845A (es) * | 2019-02-22 | 2021-09-10 | Catalent Uk Swindon Zydis Ltd | Minimizacion de la aglomeracion de material de revestimiento de particula de medicamento durante el almacenaje para estabilizar los tiempos de desintegracion de productos farmaceuticos. |
| PL3927322T3 (pl) | 2019-02-22 | 2024-02-05 | Catalent U.K. Swindon Zydis Limited | Minimalizacja napowietrzania zawiesin podczas mieszania typu in-line |
| EP4029380A4 (en) * | 2019-09-13 | 2023-09-13 | Meiji Co., Ltd | SOLID FOOD AND SOLID MILK |
| WO2021263132A1 (en) | 2020-06-26 | 2021-12-30 | Aprecia Pharmaceuticals LLC | Rapidly-orodispersible tablets having an interior cavity |
| AR123109A1 (es) * | 2020-07-31 | 2022-10-26 | Catalent Uk Swindon Zydis Ltd | Composiciones farmacéuticas que comprenden ifa |
| WO2024108082A1 (en) | 2022-11-18 | 2024-05-23 | Aprecia Pharmaceuticals LLC | Orodispersive dosage forms containing droxidopa |
Family Cites Families (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1548022A (en) | 1976-10-06 | 1979-07-04 | Wyeth John & Brother Ltd | Pharmaceutial dosage forms |
| US4513006A (en) | 1983-09-26 | 1985-04-23 | Mcneil Lab., Inc. | Anticonvulsant sulfamate derivatives |
| US4642903A (en) | 1985-03-26 | 1987-02-17 | R. P. Scherer Corporation | Freeze-dried foam dosage form |
| US4855326A (en) | 1987-04-20 | 1989-08-08 | Fuisz Pharmaceutical Ltd. | Rapidly dissoluble medicinal dosage unit and method of manufacture |
| EP0418596A3 (en) | 1989-09-21 | 1991-10-23 | American Cyanamid Company | Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form |
| US5178878A (en) | 1989-10-02 | 1993-01-12 | Cima Labs, Inc. | Effervescent dosage form with microparticles |
| US5578322A (en) | 1990-11-30 | 1996-11-26 | Yamanouchi Pharmaceutical Co., Ltd. | Quick release coated preparation |
| DE4200821A1 (de) | 1992-01-15 | 1993-07-22 | Bayer Ag | Geschmacksmaskierte pharmazeutische mittel |
| US5518730A (en) | 1992-06-03 | 1996-05-21 | Fuisz Technologies Ltd. | Biodegradable controlled release flash flow melt-spun delivery system |
| US5380473A (en) | 1992-10-23 | 1995-01-10 | Fuisz Technologies Ltd. | Process for making shearform matrix |
| WO1995001782A2 (en) | 1993-07-09 | 1995-01-19 | R.P. Scherer Corporation | Method for making freeze dried drug dosage forms |
| US5490962A (en) * | 1993-10-18 | 1996-02-13 | Massachusetts Institute Of Technology | Preparation of medical devices by solid free-form fabrication methods |
| US5738875A (en) | 1994-10-28 | 1998-04-14 | R.P. Scherer Corporation | Process for preparing solid pharmaceutical dosage forms |
| US5607697A (en) | 1995-06-07 | 1997-03-04 | Cima Labs, Incorporated | Taste masking microparticles for oral dosage forms |
| WO1998036738A1 (en) | 1997-02-20 | 1998-08-27 | Therics, Inc. | Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same |
| FR2766089B1 (fr) | 1997-07-21 | 2000-06-02 | Prographarm Lab | Comprime multiparticulaire perfectionne a delitement rapide |
| UA65607C2 (uk) * | 1998-03-04 | 2004-04-15 | Орто-Макнейл Фармацевтикал, Інк. | Фармацевтична композиція (варіанти) та спосіб її приготування |
| EE05147B1 (et) | 1999-07-09 | 2009-04-15 | Ortho-Mcneil Pharmaceutical, Inc. | Suukaudselt manustatav maskeeritud maitsega vedel preparaat |
| AP2002002410A0 (en) * | 1999-08-04 | 2002-03-31 | Ranbaxy Laboratories Ltd | Hydrodynamically Balancing Oral Drug Delivery System |
| DE19940944B4 (de) | 1999-08-31 | 2006-10-12 | Grünenthal GmbH | Retardierte, orale, pharmazeutische Darreichungsformen |
| DE60116758T2 (de) * | 2000-05-18 | 2006-11-02 | Therics, Inc. | Einkapselung eines toxischen kerns in einen nicht-toxischen bereich in einer oralen darreichungsform |
| WO2003097018A1 (en) * | 2002-02-04 | 2003-11-27 | Ranbaxy Laboratories Limited | Hydrodynamically balancing oral drug delivery system with biphasic release |
| DE60226012T2 (de) | 2001-03-05 | 2009-05-14 | Ortho-Mcneil-Janssen Pharmaceuticals, Inc. | Geschmacksmaskierte pharmazeutische formulierungen |
| ES2262851T3 (es) * | 2001-10-29 | 2006-12-01 | Therics, Inc. | Un sistema y metodo para compresion unaxial de un articulo, tal como una forma dosificadora estampada tridimensionalmente. |
| EP1439824A2 (en) * | 2001-10-29 | 2004-07-28 | Therics, Inc. | Three-dimensional suspension printing of dosage forms |
| FR2838647B1 (fr) | 2002-04-23 | 2006-02-17 | Particules enrobees a liberation prolongee, leur procede de preparation et comprimes les contenant | |
| EP1536774A1 (en) * | 2002-09-04 | 2005-06-08 | Ranbaxy Laboratories Limited | Taste masked dosage forms and processes for their preparation |
| EP1581197A1 (en) | 2002-12-11 | 2005-10-05 | Ranbaxy Laboratories, Limited | Coating composition for taste masking coating and methods for their application and use |
| NZ544007A (en) | 2003-05-07 | 2009-05-31 | Samyang Corp | Highly plastic granules for making fast melting tablets |
| FR2858556B1 (fr) | 2003-08-06 | 2006-03-10 | Galenix Innovations | Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation |
| WO2005020961A1 (en) | 2003-08-28 | 2005-03-10 | Sandoz Ag | Pharmaceutical composition comprising anticonvulsant with taste mask coating |
| AU2004312083A1 (en) | 2003-12-29 | 2005-07-21 | Alza Corporation, Inc. | Drug granule coatings that impart smear resistance during mechanical compression |
| JP2008507508A (ja) * | 2004-07-22 | 2008-03-13 | 株式會社アモーレパシフィック | トピラメート徐放性製剤及びその製造方法 |
| US20060127479A1 (en) | 2004-10-08 | 2006-06-15 | Natrajan Kumaraperumal | Solvent free taste masked pharmaceutical compositions |
| US20060182796A1 (en) | 2005-02-03 | 2006-08-17 | Abrika Pharmaceuticals, Inc. | Taste masked pharmaceutical compositions |
| US20070092553A1 (en) | 2005-10-21 | 2007-04-26 | Pfab Lp | Compositions and methods of making rapidly dissolving lonically masked formulations |
| US9744137B2 (en) * | 2006-08-31 | 2017-08-29 | Supernus Pharmaceuticals, Inc. | Topiramate compositions and methods of enhancing its bioavailability |
| EP2061431B1 (en) * | 2006-12-04 | 2013-04-24 | Supernus Pharmaceuticals, Inc. | Enhanced immediate release formulations of topiramate |
| AU2008318851B2 (en) * | 2007-10-31 | 2014-04-17 | Mcneil-Ppc, Inc. | Orally disintegrated dosage form |
| WO2009106824A2 (en) * | 2008-02-25 | 2009-09-03 | Cipla Limited | Pharmaceutical formulations |
| US20120040001A1 (en) | 2009-02-12 | 2012-02-16 | Fuji Chemical Industry Co., Ltd. | Disintegrating particle composition and rapidly disintegrating compression-molded material used the same |
| US20100285130A1 (en) | 2009-05-06 | 2010-11-11 | Monosol Rx, Llc | Coating of complexed actives in film formulations |
| JP2012528819A (ja) | 2009-06-04 | 2012-11-15 | ビーエーエスエフ ソシエタス・ヨーロピア | 味マスク活性成分含有口腔内崩壊性投薬形態 |
| US20120207836A1 (en) * | 2009-08-19 | 2012-08-16 | Bayer Pharma Aktiengesellschaft | Drug delivery systems (wafer) for pediatric use |
| UY33173A (OSRAM) * | 2010-01-08 | 2011-07-29 | Eurand Inc | |
| JP6133009B2 (ja) * | 2010-08-11 | 2017-05-24 | 協和発酵キリン株式会社 | トピラマート顆粒 |
| US9381154B2 (en) * | 2011-06-09 | 2016-07-05 | Xerox Corporation | Direct inkjet fabrication of drug delivery devices |
-
2014
- 2014-03-14 CA CA2906172A patent/CA2906172C/en active Active
- 2014-03-14 ES ES14763925T patent/ES2761407T3/es active Active
- 2014-03-14 HK HK16101295.2A patent/HK1213473A1/zh unknown
- 2014-03-14 EP EP14763925.6A patent/EP2968181B1/en active Active
- 2014-03-14 JP JP2016503003A patent/JP6466399B2/ja active Active
- 2014-03-14 AU AU2014228861A patent/AU2014228861B2/en active Active
- 2014-03-14 CN CN201480015723.7A patent/CN105050588B/zh active Active
- 2014-03-14 WO PCT/US2014/029168 patent/WO2014144661A1/en not_active Ceased
- 2014-03-14 MX MX2015012135A patent/MX365914B/es active IP Right Grant
-
2015
- 2015-08-27 US US14/837,354 patent/US9492380B2/en active Active
-
2016
- 2016-08-23 US US15/244,563 patent/US10420785B2/en active Active
-
2018
- 2018-08-22 AU AU2018220049A patent/AU2018220049B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2014228861B2 (en) | 2018-05-24 |
| AU2018220049A1 (en) | 2018-09-06 |
| CA2906172A1 (en) | 2014-09-18 |
| AU2018220049B2 (en) | 2020-07-09 |
| WO2014144661A8 (en) | 2015-08-27 |
| US10420785B2 (en) | 2019-09-24 |
| ES2761407T3 (es) | 2020-05-19 |
| EP2968181A4 (en) | 2016-04-13 |
| EP2968181B1 (en) | 2019-10-16 |
| WO2014144661A1 (en) | 2014-09-18 |
| WO2014144661A4 (en) | 2014-11-13 |
| EP2968181A1 (en) | 2016-01-20 |
| CN105050588A (zh) | 2015-11-11 |
| CA2906172C (en) | 2021-12-21 |
| US9492380B2 (en) | 2016-11-15 |
| HK1213473A1 (zh) | 2016-07-08 |
| CN105050588B (zh) | 2019-01-15 |
| US20150366801A1 (en) | 2015-12-24 |
| US20160361335A1 (en) | 2016-12-15 |
| HK1214768A1 (en) | 2016-08-05 |
| AU2014228861A1 (en) | 2015-10-08 |
| MX2015012135A (es) | 2015-11-25 |
| JP2016514686A (ja) | 2016-05-23 |
| JP6466399B2 (ja) | 2019-02-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2015012135A (es) | Forma de dosificacion de topiramato dispersable rapidamente. | |
| IL271352B (en) | A pharmaceutical preparation containing a derivative of glutarimide and its use in the treatment of eosinophilic diseases | |
| EP2967052A4 (en) | COMPOSITIONS AND METHOD FOR IMMUNOMODULATION IN PLANTS | |
| WO2011115725A3 (en) | Indazole compounds as kinase activity modulators for the treatment of cancer and related disorders | |
| EP3160493A4 (en) | Compositions and methods to regulate renalase in the treatment of diseases and disorders | |
| SG10201808104RA (en) | Cenicriviroc for the treatment of fibrosis | |
| TWD174792S (zh) | 端蓋 | |
| PH12016500284B1 (en) | Oral care composition | |
| HUE055773T2 (hu) | Epinefrin finom részecskék és módszerek azok alkalmazására az epinefrinre reagáló állapotok kezelésében | |
| IL245738A0 (en) | Oxindole derivatives, ways of their preparation and their therapeutic use in the treatment of ampk-related diseases | |
| MY183106A (en) | Fine dry particulate retinoid active agent compostions and topical formulations including the same | |
| JP2016535794A5 (ja) | 急速崩壊性固体剤形 | |
| MA55947A (fr) | Compositions pharmaceutiques et utilisations dirigées vers des troubles d'entreposage lysosomial | |
| MX2016006087A (es) | Formulaciones de desintegracion rapida y metodos de uso. | |
| MX367926B (es) | Composicion farmaceutica para liberacion sostenida de lanreotida. | |
| SI2874600T1 (sl) | Farmacevtski sestavek za zdravljenje hripavosti ali bolečin v grlu | |
| EP2964185A4 (en) | PREPARATIONS FOR TREATMENT OF SLEEP RELATED ATMOSPHERES | |
| FR2992219B1 (fr) | Composition pour le traitement de l'hypocalcemie chez les ruminants | |
| PH12017500763A1 (en) | Nutritional compositions containing a prebiotic and lactoferrin and uses thereof | |
| MY197725A (en) | A water purification composition | |
| AR095143A1 (es) | Dispersión sólida que comprende cilostazol amorfo y proceso de preparación | |
| GB201315072D0 (en) | Novel compounds and pharmaceutical compositions thereoffor the treatment of proliferative disorders | |
| AU2017260019A1 (en) | Valerian composition and related methods | |
| SG10201809280PA (en) | Combination of brexpiprazole and nalmefene and use thereof for treating substance-related disorders | |
| EP3240562A4 (en) | Compositions and methods for delivering lypophilic agents to dental pulp and for enhancing dentin production |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB | Transfer or rights |
Owner name: APRECIA PHARMACEUTICALS LLC |
|
| FG | Grant or registration |